| Patent | Date |
|---|
Substituted quinoline compounds
Grant 7,468,378 - Bertinato , et al. December 23, 2 | 2008-12-23 |
Triamide-substituted heterobicyclic compounds
Grant 7,393,958 - Bertinato , et al. July 1, 2 | 2008-07-01 |
Triamide-substituted heterobicyclic compounds
Grant 7,368,573 - Bertinato , et al. May 6, 2 | 2008-05-06 |
Substituted Heteroaryl- And Phenylsulfamoyl Compounds
App 20080090829 - HAMANAKA; ERNEST S. | 2008-04-17 |
Substituted heteroaryl- and phenylsulfamoyl compounds
Grant 7,262,318 - Hamanaka , et al. August 28, 2 | 2007-08-28 |
Triamide-substituted heterobicyclic compounds
App 20070093525 - Bertinato; Peter ; et al. | 2007-04-26 |
Substituted Heteroaryl- and Phenylsulfamoyl Compounds
App 20060258723 - Hamanaka; Ernest S. ; et al. | 2006-11-16 |
Substituted Heteroaryl- and Phenylsulfamoyl Compounds
App 20060229363 - Hamanaka; Ernest S. | 2006-10-12 |
Triamide-substituted Heterobicyclic Compounds
App 20060223851 - Bertinato; Peter ; et al. | 2006-10-05 |
Substituted heteroaryl- and phenylsulfamoyl compounds
App 20050288340 - Hamanaka, Ernest S. | 2005-12-29 |
N-[(substituted five-membered di-or triaza diunsaturated ring) carbonyl] guanidine derivatives for the treatment of ischemia
Grant 6,974,813 - Hamanaka , et al. December 13, 2 | 2005-12-13 |
Substituted quinoline compounds
App 20050234099 - Bertinato, Peter ; et al. | 2005-10-20 |
Substituted heteroaryl- and phenylsulfamoyl compounds
App 20050228015 - Hamanaka, Ernest S. ; et al. | 2005-10-13 |
Use of corticotropin releasing factor antagonists and related compositions
Grant 6,777,404 - Hamanaka , et al. August 17, 2 | 2004-08-17 |
Use of corticotropin releasing factor antagonists and related compositions
App 20030199527 - Hamanaka, Ernest S. ; et al. | 2003-10-23 |
N-[(substituted five-membered di-or triaza diunsaturated ring)carbonyl] guanidine derivatives for the treatment of ischemia
App 20030149043 - Hamanaka, Ernest S. ; et al. | 2003-08-07 |
N-[(substituted five-membered di- or triaza diunsaturated ring)carbonyl] guanidine derivatives for the treatment of ischemia
Grant 6,492,401 - Hamanaka , et al. December 10, 2 | 2002-12-10 |
Mutual salt of amlodipine and atorvastatin
Grant 6,262,092 - Chang , et al. July 17, 2 | 2001-07-17 |
N-aryl and N-heteroarylurea derivatives as inhibitors of acyl coenzyme A: Cholesterol acyl transferase (ACAT)
Grant 6,001,860 - Hamanaka December 14, 1 | 1999-12-14 |
N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT)
Grant 5,656,634 - Chang , et al. August 12, 1 | 1997-08-12 |
4-aryl-3-(heteroarylureido)quinoline derivatves
Grant 5,596,001 - Hamanaka January 21, 1 | 1997-01-21 |
4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
Grant 5,565,472 - Hamanaka October 15, 1 | 1996-10-15 |
Intermediates for making N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT)
Grant 5,362,878 - Chang , et al. November 8, 1 | 1994-11-08 |
2-alkylthiopenem derivatives
Grant 4,619,924 - Hamanaka October 28, 1 | 1986-10-28 |
| 